normal phenotype
|
|
• mice are fertile with no abnormal phenotype
|
Analysis Tools|
Allele Symbol Allele Name Allele ID |
Med12tm1.1Hsch targeted mutation 1.1, Heinrich Schrewe MGI:4839485 |
||||||||||||||||||||||||||||
| Summary |
6 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
|
• mice are fertile with no abnormal phenotype
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
|
• only one female in 16 live births
|
|
|
• fewer female embryos from a cross of hemizygous males and homozygous cre expressing females at E13.5
|
|
|
• neural tube defects of variable severity at E11.5 in females
|
|
|
• in 30% of E12.5 mice
|
|
|
• neural tube defects of variable severity at E11.5 in females
|
|
|
• in 30% of E12.5 mice
|
|
|
• exencephaly and spina bifida in 63% of mice over E12.5
|
|
|
• some calvarial bones missing
|
|
|
• splayed spina processes
|
|
|
• in 18 of 22 mice
|
|
|
• some calvarial bones missing
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
|
• protein levels of ryanodine receptor (RyR) are decreased in P7 hearts while protein levels of ATP2A2/SERCA2a which rapidly pumps Ca2+ into the sarcoplasmic reticulum (SR) are decreased in P7 hearts and in 8-week-old heart ventricles
• PLN (phospholamban), an inhibitor of ATP2A2/SERCA2a, is hyperphosphorylated in hearts with no significant change in the total protein levels of PLN in P7 hearts or 8-week-old ventricles
• protein levels of GJA1/CX43 are significantly decreased in P7 hearts and remain lower in 8-week-old heart ventricles
|
|
|
• protein levels of the ryanodine receptor (RyR), ATP2A2/SERCA2a, and GJA1/CX43 are significantly reduced in cardiomyocytes (CMs) isolated from 8-week-old hearts
• PLN (phospholamban), an inhibitor of ATP2A2/SERCA2a, is hyperphosphorylated in isolated CMs
|
|
|
• male heart weight (HW) to tibia length (TL) is significantly increased at 5 weeks with a further increase noted at 12 weeks of age
• however, male hearts appear morphologically normal at birth
|
|
|
• male hearts exhibit early and progressive thinning of the left ventricular wall
|
|
|
• left ventricular posterior wall thickness in diastole (LVPWD) and systole (LVPWS) are decreased by P7 and continue to decline with aging
|
|
|
• male hearts exhibit early and progressive dilation of the left ventricular chamber
|
|
|
• Massons trichrome staining of adult male hearts indicates an increase in interstitial cardiac fibrosis
• Picrosirius red staining shows a slight increase in fibrosis at P7 that becomes significant by 12 weeks of age
• however, no significant changes are detected in cardiomyocyte death and proliferation by TUNEL and Ki-67 staining, respectively, at P1 and 12 weeks of age
|
|
|
• male mice exhibit early-onset dilated cardiomyopathy that progresses with aging
|
|
|
• fractional shortening is significantly decreased as early as P7 and declines progressively with aging
|
|
|
• echocardiography conducted on unanesthetized male mice reveals early-onset cardiac dysfunction, with fractional shortening and heart rate significantly reduced as early as P7 and declining with aging
• left ventricular posterior wall thickness in diastole (LVPWD) and systole (LVPWS) are decreased by P7 and continue to decline with aging
• left ventricular internal dimension in diastole (LVIDD) and systole (LVIDS) are increased as early as P7 and continue to increase with aging
|
|
|
• heart rate is significantly reduced by P7 and remains significantly lower throughout adulthood, as determined at 3, 6 and 12 weeks of age
|
|
|
• electrocardiography performed on anesthetized 6-week-old male mice shows a significant decrease in heart rate to the same degree as observed in the unanesthetized state
|
|
|
• anesthetized 6-week-old male mice exhibit a prolonged QRS interval
|
|
|
• adult cardiomyocytes (CMs) isolated from 8-week-old heart ventricles show a significant increase in fractional shortening, suggesting enhanced CM contractility
|
|
|
• both adult CMs isolated from 8-week-old heart ventricles and neonatal CMs isolated from P1 heart ventricles show increased peak Ca2+ transient amplitudes without changing diastolic Ca2+ levels, indicating that more Ca2+ is released during each contraction-relaxation cycle
• moreover, both adult and neonatal CMs show accelerated reuptake of Ca2+ into the SR, as revealed by a faster cytosolic Ca2+ transient decay rate (reduced tau) and decreased duration of the Ca2+ transient
• however, total SR Ca2+ content is not altered in adult CMs
|
|
|
• Massons trichrome staining of adult male hearts indicates an increase in interstitial cardiac fibrosis
• Picrosirius red staining shows a slight increase in fibrosis at P7 that becomes significant by 12 weeks of age
• however, no significant changes are detected in cardiomyocyte death and proliferation by TUNEL and Ki-67 staining, respectively, at P1 and 12 weeks of age
|
|
|
• TEM analysis of heart left ventricles shows only a few regions containing disorganized sarcomeres at 8 weeks of age
• however, sarcomeric structure is identical to that in controls throughout most heart regions
|
|
|
• male hearts show altered calcium-handling gene expression and protein levels; all calcium-related genes investigated are significantly regulated at P1 (prior to the onset of dilated cardiomyopathy) and remain significantly down- or upregulated in the hearts and cardiomyocytes (CMs) of adult mice
|
|
|
• protein levels of the ryanodine receptor (RyR), ATP2A2/SERCA2a, and GJA1/CX43 are significantly reduced in cardiomyocytes (CMs) isolated from 8-week-old hearts
• PLN (phospholamban), an inhibitor of ATP2A2/SERCA2a, is hyperphosphorylated in isolated CMs
|
|
|
• male mice exhibit early-onset dilated cardiomyopathy that progresses with aging
|
|
|
• fractional shortening is significantly decreased as early as P7 and declines progressively with aging
|
|
|
• adult cardiomyocytes (CMs) isolated from 8-week-old heart ventricles show a significant increase in fractional shortening, suggesting enhanced CM contractility
|
|
|
• both adult CMs isolated from 8-week-old heart ventricles and neonatal CMs isolated from P1 heart ventricles show increased peak Ca2+ transient amplitudes without changing diastolic Ca2+ levels, indicating that more Ca2+ is released during each contraction-relaxation cycle
• moreover, both adult and neonatal CMs show accelerated reuptake of Ca2+ into the SR, as revealed by a faster cytosolic Ca2+ transient decay rate (reduced tau) and decreased duration of the Ca2+ transient
• however, total SR Ca2+ content is not altered in adult CMs
|
|
|
• TEM analysis of heart left ventricles shows only a few regions containing disorganized sarcomeres at 8 weeks of age
• however, sarcomeric structure is identical to that in controls throughout most heart regions
|
|
|
• male heart weight (HW) to tibia length (TL) is significantly increased at 5 weeks with a further increase noted at 12 weeks of age
• however, male hearts appear morphologically normal at birth
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
|
• fractional shortening is significantly decreased at 6 weeks but not at 3 weeks of age
|
|
|
• M-mode echocardiograms indicate a slight reduction in cardiac function at 6 weeks of age
|
|
|
• fractional shortening is significantly decreased at 6 weeks but not at 3 weeks of age
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
|
• fractional shortening is significantly decreased at both 3 and 6 weeks of age
|
|
|
• M-mode echocardiograms indicate a significant reduction in cardiac function at 6 weeks of age that is nearly identical to that in Med12tm1.1Hsch/Y Tg(Myh6-cre)2182Mds/0 males
|
|
|
• fractional shortening is significantly decreased at both 3 and 6 weeks of age
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
|
• mice are fertile with no abnormal phenotype
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/15/2026 MGI 6.29 |
|
|
|
||


